Objective:We summarized general principles related to apoptosis and reviewed the current evidence regarding apoptosis in the normal ovary during follicular atresia, ovulation, and corpus luteum formation and regression, and regression, and in the polycystic ovary.
Data sources:Published articles and abstracts from national scientific meetings were reviewed.
Data synthesis:Apoptosis is a physiologic type of cell death that may regulate tissue remodeling. In the ovary, apoptosis occurs in atretic follicles, in the ovarian epithelum at the time of ovulation, and in the corpus luteum. Certain apoptosis-related genes are expressed during follicular atresia, which suggests a role for genes in the regulation of apoptosis in the ovary. In a rat model of polycystic ovaries, apoptosis occurs in both atretric follicles and cysts.
Conclusions:Apoptosis is an important physiologic process in the ovary, and abnormalities in this process may lead to pathologic conditions. The study of ovarian apoptosis is still at an early stage, and further research will uncover the steps in this process.
3. Schwartzman RA, Cidlowski JA. Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocrinol Rev1993;14:133-151.
4.
4. Peitsch MC, Polzar B, Stephan H, et al. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J1993;12:371-377.
5.
5. Williams GT, Smith CA. Molecular regulation of apotosis: Genetic controls on cell death. Cell1993;74:777-779.
6.
6. Collins MKL, Lopez Rivas A. The control of apoptosis in mammalian cells. TIBS1993;18:307-309.
7.
7. Hopwood D, Levison DA. Atrophy and apoptosis in the cyclical human endometrium. J Pathol1976;119:159-166.
8.
8. Rotello RJ, Hocker MB, Gerschenson LE. Biochemical evidence for programmed cell death in rabbit uterine epithelium. Am J Pathol1989;134:491-495.
9.
9. Adashi EY. The ovarian life cycle. In: Yen SSC, Jaffe RB, eds. Reproductive endocrinology. 3rd ed.Philadelphia: WB Saunders, 1991;181-237.
10.
10. Hurwitz FM, Adashi EY. Ovarian follicular atresia as an apoptotic process: A paradigm for programmed cell heath in endocrine tissues. Mol Cell Endocrinol1993;84:C19-C23.
11.
11. Kerr JFK, Harmon BV. Definition and incidence of apoptosis: An historical perspective. In: Apoptosis. The Molecular Molecular Biology. 1992;3:5-29.
12.
12. Lockshin RA, Zakeri Z. Programmed cell death and apoptosis: In: Apoptosis. The Molecular Basis of Cell Death. Current Communications in Cell and Molecular Biology. 1992;3:46-60.
13.
13. Eastman A. Apoptosis: A product of programmed and unprogrammed cell death. Toxicol Appl Pharmacol1993;121:160-164.
14.
14. Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis1990;11:847-853.
15.
15. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature1980;284:555-556.
16.
16. Afanas'ev VN, Korol' BA, Mantsgyn YA, Nelipovich PA, Pechatnikov VA, Umansky SR. Flow cytometry and biochemical analysis of DNA degradation characteristic of two types of cell death. FEBS Lett1986;194:347-350.
17.
17. Tilly JL, Hsueh AJW. Microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNA fragmentation. J Cell Physiol1993;154:519-526.
18.
18. Gavrieli Y, Shermam Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol1992;119:493-501.
19.
19. Wijsman JH, Jonker RR, Keijzer R, Van De Velde CJH, Cornelises CJ, Van Dierendonck JH. A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J Histochem Cytochem1993;41:7-12.
20.
20. Gorczyca W, Gong J, Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal edoxynucleotidyl transferase and nick translation assays. Cancer Res1993;53:1945-1951.
21.
21. Alles AJ, Sulik KK. Retinoic acid-induced limb reduction defects: Perturbation of zones of programmed cell death as a pathogenetic mechanism. Teratology1989;40:163-171.
22.
22. Kerr JFR. Shrinkage necrosis: A distinct mode of cellular death. J Pathol1971;105:13-20.
23.
23. Potten CS. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev1992;11:179-195.
24.
24. Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh J-E. Active cell death in hormonedependent tissues. Cancer Metastasis Rev1992;11:197-220.
25.
25. Wyllie AH, Kerr JFR, Macaskill IAM, Currie AR. Adrenocortical cell deletion: The role of ACTH. J Pathol1973;111:85-94.
26.
26. Kerr JFR, Searle J. Deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows Arch1973;13:87-102.
27.
27. Strange R, Li F, Saurer S, Burkhardt A, Friis RR. Apoptotic cell death and tissue remodeling during mouse mammary gland involution. Development1992;115:49-58.
28.
28. Gobe GC, Axelsen RA. Genesis of renal tubular atrophy in experimental hydronephrosis in the rat: Role of apoptosis. Lab Invest1987;56:273-281.
29.
29. Columbano A, Ledda-Columbano GM, Coni PP, et al. Occurrence of cell death (apoptosis) during the involution of liver hyperplasia. Lab Invest1985;52:670-675.
30.
30. Ledda-Columbano GM, Columbano A, Coni P, Faa G, Pani P. Cell deletion by apoptosis during regression of renal hyperplasia. Am J Pathol1989;135:657-662.
31.
31. Oates PS, Morgan RGH, Light AM. Cell death (apoptosis) during pancreatic involution after raw soya flour feeding in the rat. Am J Physiol1986;250:G9-G14.
32.
32. UcKun FM, Tuel-Ahlgren L, Song CW, et al. Ionizing radiation stimulates unidentified tyrosine-sspecific protein kinase in human B-lymphocyte precursors, triggering apoptosis and clonogenic cell death. Proc Natl Acad Sci USA1992;89:9005-9009.
33.
33. Dive C, Hickman JA. Drug-target interactions: Only the first step in the commitment to a programmed cell death?Br J Cancer1991;64:192-196.
34.
34. Wyllie AH. Apoptosis and the regulation of cell umbers in normal and neoplastic tissues: An overview. Cancer Metastasis Rev1992;11:95-103.
35.
35. Dedera DA, Waller EK, LeBrun DP, et al. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell1993;74:777-779.
36.
36. McCarthy NJ, Smith CA, Williams GT. Apoptosis in the development of the immune system: Growth factors, clonal selection and bcl-2. Cancer Metastasis Rev1992;11:157-178.
37.
37. Schmid DS, Tite JP, Ruddle NH. DNA fragmentation: Manifestation of target cell destruction mediated by cytotoxic T-cell lines, lymphotoxin-secreting helper T-cell clones and cell-free lymphotoxin-containing supernatant. Proc Natl Acad Sci USA1986;83:1881-1885.
38.
38. Raff MC. Social controls on cell survival and cell death. Nature1992;356:397-400.
39.
39. Barres BA, Hart IK, Coles HSR, et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell1992;70:31-46.
40.
40. Lin J-K, Chou C-K. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1. Cancer Res1992;52:385-388.
41.
41. Yanagihara K, Tsumuraya M. Transforming growth factor β1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res1992;52:4042-4045.
42.
42. Oberhammer F, Bursch W, Parzefall W, et al. Effect of transforming growth factor β on cell death of cultured rat hepatocytes. Cancer Res1991;51:2478-2485.
43.
43. Lotem J, Sachs L. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood1992;80:1750-1757.
44.
44. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature1990;343:76-79.
45.
45. Rodriguez-Tarduchy G, Collins MKL, Garcia I, Lopez-Rivas A. Insulin-like growth factor-I inhibits apoptosis in Il-3-dependent hemopoietic cells. J Immunol1992;149:535-540.
46.
46. Schwall RH, Robbins K, Jardieu P, Chang L, Lai C, Terrell TG. Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology1993;18:347-356.
47.
47. Bursch W, Liehr JG, Sirbasku DA, Putz B, Taper H, Shulte-Hermann R. Control of cell death (apoptosis) by diethylstilbestrol in an estrogen-dependent kidney tumor. Carcinogenesis1991;12:855-860.
48.
48. Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV. A novel domain within the 55kd TNF receptor signals cell death. Cell1993;74:845-853.
49.
49. Itih N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell1991;66:233-243.
50.
50. Martin DP, Schmidt RE, DiStefano PS, Lowry OH, Carter JG, Johnson EM Jr. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell biol1988;106:829-844.
51.
51. Owens GP, Hahn WE, Cohen J. Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol Cell Biol1991;11:4177-4188.
52.
52. Duke RC, Cohen JJ. IL-2 addiction: Withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res1986;5:289-299.
53.
53. Parchment RE. Programmed cell death (apoptosis) in murine blastocysts: Extracellular free radicals, polyamines, and other cytotoxic agents. In Vivo1991;5:493-500.
54.
54. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell1993;75:241-251.
55.
55. Ellis RE, Yuan J, Horvitz R. Mechanisms and functions of cell death. Ann Rev Cell Biol1991;7:663-698.
56.
56. Hengartner MO, Ellis RE, Horvitz HR. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature1992;356:494-499.
57.
57. Vaux, DL, Weissman IL, Kim SK. Prevention fo programmed cell death in Caenorhabditis elegans by human bcl-2. Science1992;258:1955-1956.
58.
58. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature1992;359:552-554.
59.
59. Evan GI, Wyllie AH, Gillbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell1992;69:119-128.
60.
60. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell1993;74:823-832.
61.
61. Buttyan R, Olsson CA, Pintar J, et al. Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol1989;9:3473-3481.
62.
62. Clarke AR, Purdie CA, Harrison DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature1993;362:849-852.
63.
63. Lowe Sw, Ruley HE, Jacks T, Housman DE. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell1993;74:957-967.
65. Smeyne RJ, Vendrell M, Hayward M, et al. Continuous c-fos expression precedes programmed cell death in vivo. Nature1993;363:166-169.
66.
66. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature1992;356:314-317.
67.
67. Watanabe-Fukunaga R, Brannan CI, Itoh N, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol1992;148:1274-1279.
68.
68. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell1993;75:1169-1178.
69.
69. Wadhwa R, Kaul SC, Sugimoto Y, Mitsui Y. Induction of cellular senescence by transfection of cytosolic mortalin cDNA in NIH 3T3 cells. J Biol Chem1993;268:22239-22242.
70.
70. O'Shea JD, Nightingale MG, Chamley WA. Changes in small blood vessels during cyclical luteal regression in sheep. Biol Reprod1977;17:162-177.
71.
71. O'Shea JD, Hay MF, Cran DG, Ultrastructural changes in the theca interna during follicular atresia in sheep. J Reprod Fertil1978;54:183-187.
72.
72. Zeleznik AJ, Ihrig LL, Bassett SG. Developmental expression of Ca++-Mg++-dependent endonuclease activity in rat granulosa and luteal cells. Endocrinology1989;125:2218-2220.
73.
73. Tilly JL, Kowalski KI, Johnson AL, Hsueh AJW. Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology1991;129:2799-2801.
74.
74. Tilly JL, Kowalski KI, Schomberg DW, Hsueh AJW. Apoptosis in atretic ovarian follicles is associated with selective decreases in messenger ribonucleic acid transcripts for gonadotropin receptors and cytochrome P450 aromatase. Endocrinology1992;131:1670-1676.
75.
75. Hughes FM, Gorospe WC. Biochemical identification of apoptosis (programmed cell death) in granulosa cells; Evidence for a potential mechanism underlying follicular atresia. Endocrinology1992;129:2415-2422.
76.
76. Tilly JL, Billig H, Kowalski KI, Hsueh AJW. Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism. Mol Endocrinol1992;6:164-150.
77.
77. Palumbo A, Yeh J. In situ localization of apoptosis in the rat ovary: A role for apoptosis in follicular atresia. Biol Reprod1994;51:888-895.
78.
78. Pesce M, Farrace MG, Piacentini M, Dolci S, Defelici M. Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development1993;118:1089-1094.
79.
79. Billig H, Furuta I, Huseh AJW. Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology1993;133:2204-2212.
